The profound impact of FGFR4 inactivation on tumor take might again be related to the above-described impact of FGFR4 on FAK expression, which was confirmed in vivo by immunoblots of xenograft protein extracts (Fig. 6G). This evidence concerns the gene PTK2 and neoplasm.